<DOC>
	<DOCNO>NCT01349257</DOCNO>
	<brief_summary>The aim clinical study compare lung exposure content trial drug administration fix combination beclomethasone formoterol deliver via new Chiesi dry powder inhaler comparison beclomethasone formoterol deliver via pressurise meter dose inhaler ( pMDI ) use spacer device . To determine lung exposure , treatment administer charcoal block .</brief_summary>
	<brief_title>Pharmacokinetic Clinical Study CHF1535 NEXT DPI® Versus CHF1535 pMDI</brief_title>
	<detailed_description />
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<mesh_term>Charcoal</mesh_term>
	<criteria>1 . Male female adult ( ≥18 ≤ 70 year old ) . 2 . Written inform consent obtain patient prior studyrelated procedure . 3 . Diagnosis asthma define GINA guideline , update 2009 , least 6 month screen visit . 4 . Asthmatic patient already treat low medium daily dose ICS ( e.g . BDP equivalent ≤ 1000 µg/die ) low dose ICS/LABA fix combination ( e.g . salmeterol/fluticasone 100/500 µg/die ) . 5 . Patients prebronchodilator force expiratory volume one second ( FEV1 ) ≥ 60 % ≤ 90 % predicted value . 6 . Non exsmokers smoke less 5 packyears stop smoke least 1 year . ( Pack/year : number cigarette smoke per day multiply number year smoking/20 ) . 7 . Ability proper use pMDI plus spacer DPI device . 8 . A cooperative attitude compliant study procedure . 9 . Body mass index ( BMI ) ≥18.5 ≤ 32 kg/m2 1 . Pregnant lactate woman woman physiologically capable become pregnant UNLESS meet follow definition postmenopausal : 12 month natural ( spontaneous ) amenorrhea 6 month spontaneous amenorrhea use one follow acceptable method contraception . surgical sterilization ( e.g . bilateral tubal ligation , hysterectomy ) hormonal contraception ( implantable , patch , oral ) form effective contraception include placement intrauterine device ( IUD ) intrauterine system ( IUS ) barrier method contraception : condom occlusive cap ( diaphragm cervical/vault cap ) spermicidal cream/foam/gel/ suppository . 2 . Significant seasonal variation asthma asthma occur episodic exposure allergen chemical sensitizer . 3 . History near fatal asthma ( e.g . brittle asthma , hospitalization asthma exacerbation Intensive Care Unit ) . 4 . Patients abnormal QTcF Screening Visit : QTcF &gt; 450 msec male subject QTcF &gt; 470 msec female subject . 5 . Diagnosis COPD define current GOLD guideline , updates 2009 . 6 . Hospitalization due asthma exacerbation within 1 month prior screen visit runin period . 7 . Lower respiratory tract infection within one month prior screen randomization . 8 . History cystic fibrosis , bronchiectasis alpha1 antitrypsin deficiency . 9 . History drug addiction excessive use alcohol ( weekly intake excess 28 unit alcohol ; one unit glass beer , wine measure spirit ) , excessive consumption xanthine contain substance ( daily intake excess 5 cup coffee , tea , cola , etc ) psychological emotional problem likely invalidate inform consent , limit ability subject comply protocol requirement ; 10 . Diagnosis restrictive lung disease . 11 . Patients treat oral parenteral corticosteroid previous 2 month screen visit ( 3 month parenteral depot corticosteroid ) . 12 . Intolerance contraindication treatment beta2agonists and/or inhaled corticosteroid allergy component study treatment . 13 . Having receive investigational drug within 1 month screen visit . 14 . Significant medical history and/or treatment cardiac , renal , neurological , hepatic , endocrine disease , laboratory abnormality indicative significant underlying condition , may interfere patient 's safety , compliance , study evaluation , accord investigator 's opinion . 15 . Any patient active cancer history cancer le 5 year disease free survival time ( whether evidence local recurrence metastasis ) . Localized basal cell carcinoma ( without metastasis ) skin acceptable .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Asthmatic patient</keyword>
</DOC>